In HCC, activation of the IL‐6/STAT3 pathway directly enhances the expression of TIMP‐1 in liver cancer cells, converting normal hepatic fibroblasts to cancer‐associated fibroblasts, thus altering the tumour microenvironment and promoting tumourigenesis. This evidence concerns the gene IL6 and hepatocellular carcinoma.